123 related articles for article (PubMed ID: 3722196)
1. Lipid-peptide association and activation of lecithin:cholesterol acyltransferase. Effect of alpha-helicity.
Ponsin G; Hester L; Gotto AM; Pownall HJ; Sparrow JT
J Biol Chem; 1986 Jul; 261(20):9202-5. PubMed ID: 3722196
[TBL] [Abstract][Full Text] [Related]
2. In vitro binding of synthetic acylated lipid-associating peptides to high-density lipoproteins: effect of hydrophobicity.
Ponsin G; Strong K; Gotto AM; Sparrow JT; Pownall HJ
Biochemistry; 1984 Oct; 23(22):5337-42. PubMed ID: 6439239
[TBL] [Abstract][Full Text] [Related]
3. Effect of end group blockage on the properties of a class A amphipathic helical peptide.
Venkatachalapathi YV; Phillips MC; Epand RM; Epand RF; Tytler EM; Segrest JP; Anantharamaiah GM
Proteins; 1993 Apr; 15(4):349-59. PubMed ID: 8460106
[TBL] [Abstract][Full Text] [Related]
4. Activation of lecithin:cholesterol acyltransferase by a synthetic model lipid-associating peptide.
Pownall HJ; Hu A; Gotto AM; Albers JJ; Sparrow JT
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3154-8. PubMed ID: 6774331
[TBL] [Abstract][Full Text] [Related]
5. Studies of synthetic peptide analogs of the amphipathic helix. Effect of charge distribution, hydrophobicity, and secondary structure on lipid association and lecithin:cholesterol acyltransferase activation.
Epand RM; Gawish A; Iqbal M; Gupta KB; Chen CH; Segrest JP; Anantharamaiah GM
J Biol Chem; 1987 Jul; 262(19):9389-96. PubMed ID: 3597415
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional properties of the 154-171 wild-type and variant peptides of human lecithin-cholesterol acyltransferase.
Peelman F; Goethals M; Vanloo B; Labeur C; Brasseur R; Vandekerckhove J; Rosseneu M
Eur J Biochem; 1997 Nov; 249(3):708-15. PubMed ID: 9395317
[TBL] [Abstract][Full Text] [Related]
7. Lecithin:cholesterol acyltransferase activation by synthetic amphipathic peptides.
Subbarao NK; Fielding CJ; Hamilton RL; Szoka FC
Proteins; 1988; 3(3):187-98. PubMed ID: 3255105
[TBL] [Abstract][Full Text] [Related]
8. Design of a new class of amphipathic helical peptides for the plasma apolipoproteins that promote cellular cholesterol efflux but do not activate LCAT.
Labeur C; Lins L; Vanloo B; Baert J; Brasseur R; Rosseneu M
Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):580-8. PubMed ID: 9102180
[TBL] [Abstract][Full Text] [Related]
9. Functional differentiation of amphiphilic helices of the apolipoproteins by hydrophobic moment analysis.
De Loof H; Rosseneu M; Brasseur R; Ruysschaert JM
Biochim Biophys Acta; 1987 Jan; 911(1):45-52. PubMed ID: 3098296
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of activation of lecithin:cholesterol acyltransferase by apolipoprotein A-I and an amphiphilic peptide.
Yokoyama S; Fukushima D; Kupferberg JP; Kézdy FJ; Kaiser ET
J Biol Chem; 1980 Aug; 255(15):7333-9. PubMed ID: 6771289
[No Abstract] [Full Text] [Related]
11. Binding of lecithin:cholesterol acyltransferase to reconstituted high density lipoproteins is affected by their lipid but not apolipoprotein composition.
Bolin DJ; Jonas A
J Biol Chem; 1994 Mar; 269(10):7429-34. PubMed ID: 8125962
[TBL] [Abstract][Full Text] [Related]
12. Contribution of the hydrophobicity gradient of an amphipathic peptide to its mode of association with lipids.
Pérez-Méndez O; Vanloo B; Decout A; Goethals M; Peelman F; Vandekerckhove J; Brasseur R; Rosseneu M
Eur J Biochem; 1998 Sep; 256(3):570-9. PubMed ID: 9780233
[TBL] [Abstract][Full Text] [Related]
13. Discoidal complexes of A and C apolipoproteins with lipids and their reactions with lecithin: cholesterol acyltransferase.
Jonas A; Sweeny SA; Herbert PN
J Biol Chem; 1984 May; 259(10):6369-75. PubMed ID: 6427214
[TBL] [Abstract][Full Text] [Related]
14. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein.
Laccotripe M; Makrides SC; Jonas A; Zannis VI
J Biol Chem; 1997 Jul; 272(28):17511-22. PubMed ID: 9211897
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylcholine substrate specificity of lecithin: cholestrol acyltransferase-in high density lipoproteins and in lipids dispersions.
Yokoyama S; Murase T; Akanuma Y
J Biochem; 1977 Sep; 82(3):719-24. PubMed ID: 199582
[TBL] [Abstract][Full Text] [Related]
16. Distinctive structure and function of human apolipoprotein variant ApoA-IV-2.
Weinberg RB; Jordan MK; Steinmetz A
J Biol Chem; 1990 Oct; 265(30):18372-8. PubMed ID: 2211707
[TBL] [Abstract][Full Text] [Related]
17. Chain length-function correlation of amphiphilic peptides. Synthesis and surface properties of a tetratetracontapeptide segment of apolipoprotein A-I.
Fukushima D; Yokoyama S; Kroon DJ; Kézdy FJ; Kaiser ET
J Biol Chem; 1980 Nov; 255(22):10651-7. PubMed ID: 6776121
[TBL] [Abstract][Full Text] [Related]
18. Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I.
Panzenböck U; Kritharides L; Raftery M; Rye KA; Stocker R
J Biol Chem; 2000 Jun; 275(26):19536-44. PubMed ID: 10751387
[TBL] [Abstract][Full Text] [Related]
19. Studies of synthetic peptide analogs of the amphipathic helix. Correlation of structure with function.
Chung BH; Anatharamaiah GM; Brouillette CG; Nishida T; Segrest JP
J Biol Chem; 1985 Aug; 260(18):10256-62. PubMed ID: 4019511
[TBL] [Abstract][Full Text] [Related]
20. Use of synthetic peptide analogues to localize lecithin:cholesterol acyltransferase activating domain in apolipoprotein A-I.
Anantharamaiah GM; Venkatachalapathi YV; Brouillette CG; Segrest JP
Arteriosclerosis; 1990; 10(1):95-105. PubMed ID: 2105091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
